2023 annual financial data
Viridian Therapeutics 2023 Operating cash flow margin
Direct answer
Operating cash flow margin was -58,652.87%.
Operating income was -254,450,000 USD and net income was -237,734,000 USD.
Operating cash flow was -184,170,000 USD.
Get free Viridian Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 314,000 USD
- Operating income
- -254,450,000 USD
- Net income
- -237,734,000 USD
- Operating cash flow
- -184,170,000 USD